Extended-spectrum b-lactamase (ESBL)-producing Escherichia coli has spread rapidly worldwide and poses a serious threat to human and animal health. This study collected 51 nonreplicate E. coli isolates from 14 different chicken farms in Henan Province in China from December 2007 to August 2008. The prevalence of ESBL-producing E. coli, molecular characterization of the ESBL-related bla genes, including bla TEM , bla SHV and bla CTX-M , and the susceptibilities of these bacteria to various antimicrobial agents were determined. Thirty-one of the 51 isolates were positive for an ESBL phenotype and 29 of these isolates carried one or more bla genes. Twenty-two isolates harboured bla TEM genes and 15 isolates carried bla CTX-M genes (one CTX-M-14, three CTX-M-24 and 11 CTX-M-65). One isolate carried bla TEM-57 ; the remaining bla TEM isolates carried bla TEM-1 with one silent nucleotide base variation (T18C). We believe that this is the first study to report TEM-57 in E. coli isolates. All isolates harbouring bla CTX-M-24 and bla CTX-M-14 and five of the bla CTX-M-65 isolates also harboured the bla TEM-1 gene. To our knowledge, this study is the first to describe detection of CTX-M-65producing E. coli isolated from chickens. None of the isolates contained the bla SHV gene. Conjugation experiments demonstrated that bla CTX-M and bla TEM genes could be transferred to E. coli DH5a. The results indicate that ESBL frequency has reached an alarming level in chicken isolates in China, with TEM-1 and CTX-M-65 enzymes being the two predominant b-lactamases detected.
INTRODUCTION
Extended-spectrum b-lactamases (ESBLs) are rapidly spreading worldwide (Tenover et al., 1999) and presently comprise over 500 variants (http://www.lahey.org/Studies), which are frequently encountered among human and animal clinical Enterobacteriaceae isolates (Bradford, 2001) . A typical characteristic of ESBLs is their ability to hydrolyse oxyimino-cephalosporins, which can be inhibited by blactamase inhibitors (Paterson & Bonomo, 2005) . ESBLs, particularly TEM, SHV and CTX-M enzymes, exhibit a high degree of diversity (Bonnet, 2004; Livermore et al., 2007) . ESBL genes are usually carried by plasmids, facilitating their spread among Gram-negative bacilli. Several surveillance studies have revealed a relatively high prevalence of ESBL-producing organisms in the Asia-Pacific area (Hirakata et al., 2005; Wang et al., 2005) . In particular, the CTX-M family is believed to be dominant in Asia, as it has appeared or caused outbreaks in many countries (Bonnet, 2004; Munday et al., 2004; Ryoo et al., 2005; Kiratisin et al., 2008; Xiao et al., 2008) .
Since 1994, ESBL-producing bacteria have become widely disseminated in the People's Republic of China and their molecular characterization has focused mainly on human clinical isolates (Cheng & Chen, 1994; Chanawong et al., 2002; Wang et al., 2005; Xiao et al., 2008; Liu et al., 2009) . Several studies worldwide have studied the epidemiology and molecular characterization of ESBL-producing animal clinical isolates (Batchelor et al., 2005; Briñas et al., 2005; Riaño et al., 2006; Smet et al., 2008) , whereas similar reports in China have been rare (Duan et al., 2006; Liu et al., 2007; Hu et al., 2008) . Here, we report the results of the first extensive phenotypic and molecular studies of ESBL-producing Escherichia coli isolated from 14 different chicken farms in Henan Province, China. The aim of the study was to determine the ESBL frequency in clinical E. coli isolates from chickens and to reveal basic aspects of their molecular epidemiology.
METHODS
Bacterial strains. A total of 51 non-replicate isolates were collected between December 2007 and August 2008 from 14 chicken farms in Henan Province. All samples were obtained aseptically from liver swabs as soon as the sick chickens died, and the organisms were seeded immediately on MacConkey agar. Each isolate was collected from a single chicken. The isolates were identified as E. coli using the Vitek-32 system and showed resistance to ampicillin according to the Clinical and Laboratory Standards Institute (CLSI) broth microdiffusion method (CLSI, 2007) . The azide-resistant E. coli DH5a was used as a recipient strain for conjugative transfer. E. coli ATCC 25922 (Beijing Ordinary Microbiology Strain Store Center), E. coli CF1124 (producing TEM-24; Peking University Health Science Center), E. coli ZM-7 (CTX-M-type, GenBank accession no. DQ849332, identified by our laboratory) and Klebsiella pneumoniae ATCC 700603 (producing SHV-18; Peking University Health Science Center) were used as reference strains.
Identification of ESBL producers. ESBL-producing isolates were screened by a phenotypic confirmatory test using cefotaxime, ceftazidime, cefotaxime/clavulanate (2 : 1) and ceftazidime/clavulanate (2 : 1) according to CLSI recommendations (CLSI, 2007) . All ESBL-producing isolates were collected for further investigation.
Antimicrobial susceptibility test. The antimicrobial susceptibilities of all ESBL-producing clinical isolates were determined at the same time using the CLSI broth microdilution method (CLSI, 2007) . The antimicrobial agents tested were: ceftiofur, ceftiofur/sulbactam (2 : 1), amoxicillin/clavulanate (2 : 1), cefoperazone, cefoperazone/tazobactam (2 : 1), ceftriaxone, cefepime, amikacin, gentamicin, florfenicol, doxycycline, sulfamethoxazole/trimethoprim (5 : 1) and enrofloxacin. Isolates shown to be resistant to at least three different classes of agent were classified as multidrug resistant (MDR) (Kiratisin et al., 2008) .
Characterization of genes encoding b-lactamases. As most ESBL genes have been shown to be plasmid-borne, plasmid DNA was extracted and purified using a TaKaRa MiniBEST Plasmid Purification kit. PCR amplification of bla TEM , bla SHV and bla CTX-M was performed with TaKaRa Ex Taq DNA polymerase using the primers listed in Table 1 , as described previously (Hu et al., 2006) . All PCR amplicons were verified by gel electrophoresis on a 1.0 % (w/v) agarose gel and stained with ethidium bromide (0.5 mg ml 21 ). PCR amplicons were purified, subsequently ligated into the pGEM-T Easy vector (Promega) and then sequenced. Sequencing analyses were performed online using BLAST (www.ncbi.nlm.nih.gov/BLAST/).
Conjugation.
Conjugation experiments were carried out using E. coli DH5a. Transconjugants were selected on tryptic soy agar containing 200 mg sodium azide ml 21 and 50 mg cefazolin ml 21 and their blactamase genes were confirmed by PCR as described above.
RESULTS AND DISCUSSION

E. coli isolates harbouring ESBLs
With the extensive use in poultry of b-lactam antibiotics such as amoxicillin and cephalosporins, especially extended-spectrum cephalosporins, ESBL-mediated resistance in Gram-negative bacilli has become increasingly critical, and therapeutic options for such infections are becoming limited (Hu et al., 2005; Pfaller & Segreti, 2006) . It is important to detect ESBL producers in order to know the ESBL prevalence in animal-associated bacteria and to limit the spread of these MDR organisms in veterinary settings (Ramphal & Ambrose, 2006; Liu et al., 2007) . In the present study, 60.8 % (31/51) of the isolates tested were ESBL-producing E. coli. We showed previously that only 12.9 % (4/31) of clinical Enterobacteriaceae isolates were ESBL producers (Hu et al., 2006) . Another survey (Liu et al., 2007) , in 2007, showed that the prevalence of ESBLproducing animal-associated bacteria in China was 30 % (15/50). These results indicate that the incidence of ESBLs in bacteria isolated from animals in China is increasing.
Susceptibility of ESBL-producing E. coli to antimicrobial agents
The MIC 50 /MIC 90 values of ceftiofur, ceftriaxone, cefoperazone, ceftiofur/sulbactam, amoxicillin/clavulanate, cefoperazone/tazobactam and cefepime against the 31 ESBLproducing E. coli isolates were 40/160, 32/128, 64/128, 5/10, 10/10, 4/8 and 2/4 mg ml 21 , respectively ( Table 2) . All isolates demonstrated high MICs for extended-spectrum cephalosporins whilst remaining susceptible to b-lactam/blactamase inhibitor combinations and cefepime. It is worth noting that the majority of isolates were also resistant to non-b-lactam agents, especially gentamicin (87.1 %), amikacin (80.6 %), enrofloxacin (80.6 %) and sulfamethoxazole/trimethoprim (90.3 %). In addition, 80.6 % (25/31) of the ESBL-producing strains expressed an MDR phenotype, suggesting that ESBL-producing isolates have probably acquired additional resistance genes. In order to gain a better understanding of their genetic relationships, further studies are needed to characterize the plasmids on which bla genes and other resistance genes are located.
Molecular characterization of ESBL genes
Twenty-nine of the 31 ESBL phenotype-positive E. coli isolates (93.5 %) carried bla genes (Table 3) . Two isolates did not contain bla TEM , bla SHV or bla CTX-M ; further studies will be needed to look for other ESBL genes in these isolates. Among the 29 isolates, bla CTX-M was detected in 15 (51.7 %), and 23 (79.3 %) harboured bla TEM genes. Nine of the 29 isolates (31.0 %) carried two bla genes (bla TEM and bla CTX-M ). None of the isolates contained the bla SHV gene. These findings demonstrate that bla TEM and bla CTX-M genes are the two dominant types in ESBL-producing chicken isolates and that the CTX-M-type b-lactamase is playing an increasing role in antibiotic resistance in China. Based on a conjugation assay for selected isolates, all bla genes detected were successfully transferred to transconjugants, suggesting that these genes were plasmid-borne.
One isolate carried bla TEM-57 ; the remaining bla TEM isolates carried bla TEM-1 with one silent nucleotide base variation (T18C) compared with GenBank accession no. AY293072 (TEM-1 b-lactamase). This indicated that TEM-1 is the most common b-lactamase among E. coli isolates from chickens in China. TEM-1, the most prevalent bla-encoded enzyme in human clinical isolates worldwide (Ryoo et al., 2005; Carattoli et al., 2008; Kiratisin et al., 2008; Smet et al., 2008) , is not classified as an ESBL. However, several TEM-1 derivatives confer ESBL properties (Paterson & Bonomo, 2005) . In our study, the 13 isolates carrying bla TEM-1 , in the absence of other bla genes, exhibited resistance to thirdgeneration cephalosporins, including ceftiofur, ceftriaxone and cefoperazone. The MIC 50 /MIC 90 values of these drugs were 40/80, 32/64 and 64/64 mg ml 21 , respectively. The results suggest that these 13 isolates may carry other ESBL genes that this study did not evaluate, for example OXAtype ESBLs (Paterson & Bonomo, 2005) . Compared with TEM-1, TEM-57 contains a GlyAAsp substitution at position 92 (Ambler numbering), which was first described in Proteus mirabilis in 1999 (Bonnet et al., 1999) . However, we believe that this is the first study worldwide to report TEM-57 in E. coli and the first bla TEM-57 sequence deposited in GenBank (accession no. FJ405211). Studies are needed to characterize this enzyme further.
The CTX-M family, first described in 2002 in China (Chanawong et al., 2002) and known to be the most dominant non-TEM, non-SHV ESBLs among members of the Enterobacteriaceae, is recognized as a rapidly growing family of ESBLs in Europe and Asia (Bonnet, 2004; Livermore et al., 2007) , with geographical variation in the prevalence of CTX-M cluster groups. In Asia, the CTX-M-9 cluster was found to be the most common (Cantó n & Coque, 2006; Ho et al., 2008; Kiratisin et al., 2008; Song et al., 2009) , whilst in Europe the CTX-M-1 cluster was found to predominate (Woodford et al., 2004) . The current study showed that, among 29 ESBL-producing E. coli isolates, bla CTX-M genes encoding CTX-M-14, CTX-M-24 and CTX-M-65 were found in 3.5, 10.3 and 37.9 % of the isolates, respectively, suggesting that there might be wide dissemination of different CTX-M-type b-lactamases in chicken isolates in China. Based on amino acid sequence (Doi et al., 2008) , but, to our knowledge, this is the first study to report CTX-M-65 in animal isolates, and the CTX-M-65 prevalence (37.9 %) was remarkably high. The amino acid sequence of CTX-M-65 was found to differ from that of CTX-M-14 by the substitutions of Ala80Val and Ser275Arg. Antimicrobial susceptibility tests demonstrated that the CTX-M-65 isolates exhibited a higher level of resistance (from two-to eightfold) to ceftriaxone, ceftiofur, cefoperazone, gentamicin, amikacin and florfenicol compared with CTX-M-14 and CTX-M-24 isolates, i.e. the CTX-M-65 isolates were more prone to exhibit an MDR phenotype. Therefore, these surveys indicated increasing trends not only in the prevalence of CTX-M-65 ESBLs but also in MDR phenotypes in China.
In summary, we have reported the first extensive study of the prevalence and molecular characterization of ESBLproducing E. coli isolated from chickens in Henan Province, China. This study clearly indicated that TEM-1 and CTX-M-65 are widespread in this region. Most ESBL producers were resistant to extended-spectrum cephalosporins and exhibited a high rate of the MDR phenotype.
